Towards Accelerating HBV Clinical Research in Africa

E-mail Print
Towards Accelerating HBV Clinical Research in Africa was held in Lisbon, Portugal on April 12, 2024, which was held after the conclusion of World Hepatitis Summit 2024.  

Materials

pdfAgenda

pdfParticipant List

Presentations

pdfWelcome from the Forum
Veronica Miller, Forum for Collaborative Research
Mitchell Leus, Forum for Collaborative Research

pdfSetting the Stage
Veronica Miller, Forum for Collaborative Research

Session I: Operational Research Priority: Preventing Mother-to-Child Transmission

pdfCGHE Overview on Preventing Mother-to-Child Transmission
John Ward, Coalition for Global Hepatitis Elimination

pdfWorld Health Organization Perspective
Philippa Easterbrook, World Health Organization
Olufunmilayo Lesi, World Health Organization
Session II: Operational Research Priority: Simplifying Delivery Models

pdfCGHE Overview on Simplifying Delivery Models
John Ward, Coalition for Global Hepatitis Elimination

pdfCape Coast Teaching Hospital Experience
Yvonne Nartey, Cape Coast Teaching Hospital, Ghana

Session III: Collaboration to Strengthen Diagnostic and Research Capacity in Africa

pdf"We don't have any data from Africa" - true or false?
Asgeir Johannessen, Hepatitis B in Africa Collaborative Network (HEPSANET)

pdfHBV genotypes in sub-Saharan Africa and clinical outcomes
Anna Kramvis, University of Witwatersrand

Session IV: Training, Capacity-Building, and African Ownership of Research Enterprise

pdfGlobal Health EDCTP3 Joint Undertaking
Michael Makanga, European & Developing Countries Clinical Trials Partnership (EDCTP)

pdfThe role of the African Vaccine Regulatory Forum (AVAREF) in clinical research across Africa
Chinwe Iwu-Jaja, African Vaccine Regulatory Forum (AVAREF), WHO Regional Office for Africa